Monitoring the Introduction of Pneumococcal Conjugate Vaccines into West Africa: Design and Implementation of a Population-Based Surveillance System
article has not abstract
Vyšlo v časopise:
Monitoring the Introduction of Pneumococcal Conjugate Vaccines into West Africa: Design and Implementation of a Population-Based Surveillance System. PLoS Med 9(1): e32767. doi:10.1371/journal.pmed.1001161
Kategorie:
Health in Action
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001161
Souhrn
article has not abstract
Zdroje
1. O'BrienKLWolfsonLJWattJPHenkleEDeloria-KnollM 2009 Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374 893 902
2. KlugmanKPMadhiSAHuebnerREKohbergerRMbelleN 2003 A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 1341 1348
3. CuttsFTZamanSMEnwereGJaffarSLevineOS 2005 Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365 1139 1146
4. LehmannDWillisJMooreHCGieleCMurphyD 2010 The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes. Clin Infect Dis 50 1477 1486
5. SingletonRJHennessyTWBulkowLRHammittLLZulzT 2007 Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297 1784 1792
6. [No authors listed] 2010 Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report. Wkly Epidemiol Rec 85 434 436
7. O'DempseyTJMcArdleTFLloyd-EvansNBaldehILawrenceBE 1996 Pneumococcal disease among children in a rural area of west Africa. Pediatr Infect Dis J 15 431 437
8. RocaAHillPCTownendJEgereUAntonioM 2011 Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in The Gambia: a cluster-randomized trial. PLoS Med 8 e1001107 doi:10.1371/journal.pmed.1001107
9. AdegbolaRAHillPCSeckaOIkumapayiUNLahaiG 2006 Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996–2003. Trop Med Int Health 11 1128 1135
10. HillPCAkisanyaASankarehKCheungYBSaakaM 2006 Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis 43 673 679
11. World Health Organization, Department of Vaccines and Biologicals 2001 Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. WHO/V&B/01.35. Available: http://www.who.int/entity/vaccine_research/diseases/ari/www616.pdf. Accessed 10 January 2011
12. BenguiguiYSteinF 2006 Integrated management of childhood illness: an emphasis on the management of infectious diseases. Semin Pediatr Infect Dis 17 80 98
13. JungeSPalmerAGreenwoodBMKim MulhollandEWeberMW 2006 The spectrum of hypoxaemia in children admitted to hospital in The Gambia, West Africa. Trop Med Int Health 11 367 372
14. GordonSBWalshALChapondaMGordonMASokoD 2000 Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal. Clin Infect Dis 31 53 57
15. DukeTMichaelAMgoneJFrankDWalT 2002 Etiology of child mortality in Goroka, Papua New Guinea: a prospective two-year study. Bull World Health Organ 80 16 25
16. BanyaWAO'DempseyTJMcArdleTLloyd-EvansNGreenwoodBM 1996 Predictors for a positive blood culture in African children with pneumonia. Pediatr Infect Dis J 15 292 297
17. GermanRRLeeLMHoranJMMilsteinRLPertowskiCA 2001 Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep 50 1 35; quiz CE31-37
18. SahaSDarmstadtGNaheedAArifeenSIslamM 2011 Improving the sensitivity of blood culture for Streptococcus pneumoniae. J Trop Pediatr 57 192 196
19. MadhiSAKlugmanKP 2007 World Health Organization definition of “radiologically-confirmed pneumonia” may under-estimate the true public health value of conjugate pneumococcal vaccines. Vaccine 25 2413 2419
20. MadhiSAKuwandaLCutlandCKlugmanKP 2005 The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis 40 1511 1518
21. KnollMDMoisiJCMuhibFBWonodiCBLeeEH 2009 Standardizing surveillance of pneumococcal disease. Clin Infect Dis 48 Suppl 2 S37 S48
22. AdegbolaRASeckaOLahaiGLloyd-EvansNNjieA 2005 Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 366 144 150
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 1
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Ensemble Modeling of the Likely Public Health Impact of a Pre-Erythrocytic Malaria Vaccine
- Adult Mortality Attributable to Preventable Risk Factors for Non-Communicable Diseases and Injuries in Japan: A Comparative Risk Assessment
- What Will It Take to Eliminate Pediatric HIV? Reaching WHO Target Rates of Mother-to-Child HIV Transmission in Zimbabwe: A Model-Based Analysis
- Challenging Medical Ghostwriting in US Courts